$170,000 of NOVAVAX INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines."
You can find more data on corporate lobbying on Quiver Quantitative.
NVAX Insider Trading Activity
NVAX insiders have traded $NVAX stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NVAX stock by insiders over the last 6 months:
- JAMES F YOUNG has made 0 purchases and 2 sales selling 10,000 shares for an estimated $82,208.
- RACHEL K. KING sold 4,150 shares for an estimated $37,435
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NVAX Hedge Fund Activity
We have seen 105 institutional investors add shares of NVAX stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 4,326,403 shares (+823.5%) to their portfolio in Q4 2024, for an estimated $34,784,280
- MORGAN STANLEY added 3,387,896 shares (+218.3%) to their portfolio in Q4 2024, for an estimated $27,238,683
- BANK OF MONTREAL /CAN/ removed 2,440,010 shares (-99.4%) from their portfolio in Q4 2024, for an estimated $19,617,680
- COATUE MANAGEMENT LLC removed 2,224,319 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $17,883,524
- DEEP TRACK CAPITAL, LP added 2,000,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $16,079,999
- SHAH CAPITAL MANAGEMENT added 1,333,305 shares (+13.6%) to their portfolio in Q4 2024, for an estimated $10,719,772
- TWO SIGMA ADVISERS, LP removed 1,219,700 shares (-61.0%) from their portfolio in Q4 2024, for an estimated $9,806,387
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NVAX Analyst Ratings
Wall Street analysts have issued reports on $NVAX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 11/13/2024
To track analyst ratings and price targets for NVAX, check out Quiver Quantitative's $NVAX forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
